OTLK
Outlook Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.67
−1.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 2.06x
- P/S forward
- 5.81x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -15.73x
- Price / sales
- -140.58x
- Price / cash flow
- -2.86x
Enterprise value
- Enterprise value
- $170.7M
- EV / sales
- -146.76x
- EV / EBITDA
- -2.74x
- EV / EBIT
- -3.07x
- Market cap
- $163.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026